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San-pin Wang, MD, DSc, and J. Thomas Grayston, MD, 
Seattle, Wash.; and Stockton, Calif. 
Purpose: To study surgically excised vascular tissue from lower extremities for the 
presence of Chlamydia pneumoniae, to extend the previously described association of the 
organism with atherosclerosis. 
Methods: Arterial biopsy specimens obtained from femoral and popliteal arteries during 
bypass operation for claudication were examined by immunocytochemical analysis and 
polymerase chain reaction for the presence of organisms. 
Results: C. pneumoniae was detected in atherosclerotic plaques by either method in either 
artery of 11 of 23 patients (48%). Eight of 21 popliteal and three of 18 femoral arteries 
had positive results. 
Conclusions: Detection of C. pneumoniae in peripheral rteries indicates that the organism 
is widespread in atherosclerosis of the vascular system. (J Vasc Surg 1997;26:29-31.) 
In 1992 we first reported etection of Chlamydia 
pneumoniae in coronary atheromas in autopsy cases 
from South Africa by immunocytochemical stain 
(ICC) and electron microscopy? Since then, the 
organism has been found in atherosclerotic lesions of 
three major arteries: coronary 2-7 and carotid s arteries 
and the aorta. 9-H The specimen sources included 
autopsy, atherectomy, endarterectomy, vascular sur- 
gery, and heart transplantation. Several methods 
have been used in these studies for detection of 
organisms. These include ICC, immunofluores- 
cence, polymerase chain reaction (PCR), in situ hy- 
bridization, and electron microscopy. Although cul- 
ture of the organism from arterial tissue has been 
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difficult, it has now been reported from a coronary 
artery 7and a carotid artery. 12 We now report detec- 
tion of C. pneumoniae in atherosclerotic lesions of 
peripheral arteries of lower extremities. 
MATERIALS AND METHODS 
Patients and artery tissues. Patients underwent 
operation at the Dameron Hospital Heart Institute 
in Stockton, Calif. from September 1993 to October 
1995 for arterial obstruction in the lower extremity 
with the chief complaint being claudication. Biopsy 
samples were obtained from the diseased arteries 
during bypass operation. Two pieces of arteries, each 
about 0.5 mm (range, 0.3 to 0.7 ram) in length, 
were dissected. One piece was frozen at -70 ° C for 
isolation and PCR. The other piece was fixed in 
10% buffered formalin for paraffin embedding, for 
histopathologic examination, and for ICC. Nor- 
mal popliteal and femoral arteries were not avail- 
able for testing. Therefore, biopsies of  normal ar- 
teries were obtained from patients who underwent 
vascular surgery for other causes. These arteries 
included one radial, one axillary, two aortic, and 
four internal mammary arteries. Consent forms 
were signed by the patients, and the study was 
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Table I. Chlamydia pneumoniae detected 
by ICC or PCR in atherosclerotic plaques of 
arteries of lower extremities 
No. positive~No, tested 
Arteries ICC PCR Either 
Popliteal 7/9 4/21 8/21 
Femoral 2/11 1/18 3/18 
Total 9/20 5/39 11/39 
approved by the Institute's human subject review 
committee. 
Laboratory tests. Because of the difficulty in 
isolating chlamydia from the chronic disease state, 
specific direct detection methods, ICC and PCR, 
have provided invaluable tools for demonstrating the 
presence of the organism. Four tzm sections were cut 
from paraffin blocks for histologic examination by 
hematoxylin and eosin stain and ICC using a Chla- 
mydin genus-specific mouse monoclonal antibody 
CF-2, as described previously. 2 Normal mouse ascitic 
fluid was used as a control antibody. Two sections 
were stained for ICC. Frozen tissues were homoge- 
nized by pestle and mortar. Homogenates were cen- 
trifilged at low speed to remove tissue debris. The 
clear supcrnatants were used for cell culture isola- 
tion. 2 The tissue pellets were used for PCR. 
PCR was performed with the HL-1, HR-1 
primer set as previously described. 2,a Controls con- 
sisting of mock extractions of buffer, PCR reagents 
without any specimen and with various dilutions of 
purified C. pneumonine DNA were included in each 
PCR run. Confirmation of presumptive positive 
specimens and detection of products below the sen- 
sitivity ofagarose gels were done by immuno-chemi- 
luminescence using the 474-bp Pst I C. pneumoniae- 
specific restriction fragment as a probe of Southern 
transfers. If the specimens tested negative, aliquots 
were seeded with 100 fg of C. pneumoniae DNA and 
reamplified to rule out that the negative results were 
a result of inhibition of PCR. If inhibition was ob- 
served, drop dialysis against sterile water was per- 
formed and PCR was repeated. 
To minimize the risk of specimen contamination, 
tissue homogenization, DNA extraction, sample 
preparation, PCR amplification, and product analysis 
were each performed in separate rooms. Separate 
pairs of forceps, scissors, and pestle and mortar were 
used for each tissue for tissue homogenization. 
Rooms were sterilized with germicidal lamps, and 
the laboratory benches were wiped with Absolve 
(DuPont NEN) before and after use. 
Antibodies against C. pneumoniae were measured 
by the micro-immunofluorescence test using forma- 
lin-fixed elementary bodies of C. pneumoniae strain 
AR-39. 2 
RESULTS 
Eighteen femoral arteries and 21 popliteal arter- 
ies from 23 patients were examined. Specimens of 
both femoral and popliteal arteries were obtained 
from 16 patients. Ages of these patients ranged from 
36 to 82 years, 19 (83%) were 60 years or older; 16 
(70%) were male. Eleven patients were diabetic; the 
remaining had previous history of coronary heart 
disease, coronary bypass, and hypertension. All tis- 
sues examined showed typical advanced fibrous 
plaque. 
C. pneumoniae was detected by either ICC or 
PCR in eight of 21 popliteal arteries (38.1%) and in 
three of 18 femoral arteries (16.7%; Table I). Overall, 
C. pneumoniae was detected in 11 of 39 peripheral 
arteries of lower extremities (28%), or from 11 of 23 
patients (48%) in either artery. Specimens from five 
of 11 patients with diabetes (45%) and six of 12 
patients without diabetes (50%) tested positive. Re- 
sults of ICC staining were positive in seven of the 
nine popliteal arteries and two of the 11 femoral 
arteries. Two separate sections were examined for 
each of the tissues; results from four specimens tested 
positive in both sections. Results of PCR were posi- 
tive in four of 21 popliteal arteries and one of 18 
femoral arteries. Inhibitors of PCR were demon- 
strated in two popliteal and three femoral arteries. 
Both ICC and PCR were tested in nine popliteal 
arteries. Two arteries tested positive by both tests, 
and four tested positive by ICC but negative by 
PCR. Eleven femoral arteries were tested by both 
ICC and PCR. None tested positive by both tests, 
and two tested positive by ICC but negative by PCR. 
Tcsts of the control arteries all had negative results by 
both ICC and PCR. 
Isolations were attempted with 15 popliteal and 
11 femoral arteries. None tested positive. 
Antibodies against C. pneumoniae were detected 
in all 20 patients examined. Ten patients with serum 
tested had C. pneumoniae detected by PCR or ICC. 
The average immunoglobulin G antibody titer for 
those with organism was one dilution higher than for 
those patients without organisms detected (128 vs 
64; p = 0.37). C. pneumoniae immunoglobulin A 
antibody was found in six of the 10 positive speci- 
mens and six of the 10 negative specimens' era. 
Immunoglobulin M antibody was found once, in a 
patient whose specimen tested negative for organ- 
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isms in tissue. It was in very high titer (1024), which 
suggested recent C. pneumoniae infection. 
DISCUSSION 
We have now extended the findings to include 
peripheral arteries as being possible sites of infection 
by C. pneumoniae. The detection rate in the periph- 
eral arteries of lower extremities (11 of 39; 28%) is 
similar to those of our previous studies on other 
arteries (coronary, carotid, and aorta), which ranged 
from 35% to 86% in developed lesions. 1-4,8 In other 
studies (including ours), C. pneumoniae has been 
detected with more frequency by ICC and immuno- 
fluorescence than by PCR. One study s found that 
only one of 58 atherectomy specimens had positive 
test results by PCR, but others that used PCR found 
that 45% t° and 51% it of arterial plaques had positive 
test results. Those that used antigen staining with or 
without PCR have reported a higher frequency of 
positive results. Muhlestein 6found 71 of 90 atherec- 
tomy specimens positive by immunofluorescence. 
We attributed this to the presence of inhibitors to 
PCR in atheroma tissues, s
All patients had antibodies against C. pneu- 
moniae, which reflects the high antibody prevalence 
in the general population in this age group. The 
incidence of antibody reaches 75% in elderly pa- 
tients? ~ The significance of the higher immunoglob- 
ulin G antibody titers in the patients with organism 
detected in tissue is not known. 
Detection of C. pneumoniae in peripheral arteries 
indicates the widespread nature of C. pneumoniae in 
atherosclerosis of the vascular system. The causal 
relationship between C. pneumoniae nd atheroscle- 
rosis is yet to be determined. These results should 
add to the interest in further studies to determine the 
pathogenic role of C. pneumoniae in atherosclerosis 
using animal models or human therapeutic trials. 
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